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Monocytes are effectors of the inflammatory
response to microbes. Human CD14+ monocytes
specialize in phagocytosis and production of reac-
tive oxygen species and secrete inflammatory cyto-
kines in response to a broad range of microbial
cues. Here, we have characterized the functions of
human monocytes that lack CD14 (CD14dim) and
express CD16. CD14dim monocytes were genetically
distinct from natural killer cells. Gene expression
analyses indicated similarities with murine patrolling
Gr1dim monocytes, and they patrolled the endothe-
lium of blood vessels after adoptive transfer, in
a lymphocyte function-associated antigen-1-depen-
dent manner. CD14dimmonocytes were weak phago-
cytes and did not produce ROS or cytokines in
response to cell-surface Toll-like receptors. Instead,
they selectively produced TNF-a, IL-1b, and CCL3 in
response to viruses and immune complexes contain-
ing nucleic acids, via a proinflammatory TLR7-TLR 8-
MyD88-MEK pathway. Thus, CD14dim cells are bona
fide monocytes involved in the innate local surveil-
lance of tissues and the pathogenesis of autoim-
mune diseases.
INTRODUCTION
Blood monocytes are bone marrow-derived phagocytes
involved in the innate response to bacterial, fungal, parasitic,
and viral infection (Barbalat et al., 2009; Gupta et al., 2001;ImSerbina et al., 2009; Serbina et al., 2008; Stro¨her et al., 2001).
Nonetheless, the full spectrum of monocyte function, and in
particular the specific functions of monocyte subsets, is not
yet known. Recent work has revealed heterogeneity of
monocytes, with two distinct subsets in rodents as well as in
humans (Ancuta et al., 2009; Auffray et al., 2009; Geissmann
et al., 2003; Ingersoll et al., 2010; Sunderko¨tter et al., 2004;
Zhao et al., 2009; Ziegler-Heitbrock, 2007). Akin to other leuco-
cytes, such as lymphocytes, evidence suggests that the diversity
of functions ascribed to monocytes might reflect cellular hetero-
geneity, with distinct subsets endowed with specific functions.
On the basis of in vivo studies, murine monocytes have been
separated into two subclasses. A major subset of ‘‘inflamma-
tory’’ Gr1+ monocytes specializes in the production of tumor
necrosis factor (TNF)-a, reactive oxygen species (ROS), and
nitric oxide (NO) but little interleukin (IL)-10 upon in vivo infection
with bacteria such as Listeria monocytogenes or parasites such
as Toxoplasma gondii (Serbina et al., 2008). Gr1+ monocytes
also produce type 1 interferon in response to viral ligands
(Barbalat et al., 2009). In contrast, Gr1 monocytes patrol the
blood vasculature, can differentiate into macrophages after
extravasation into tissues, and have been suggested to be asso-
ciated with tissue repair (Auffray et al., 2007; Nahrendorf et al.,
2007). Their role in response to infection is not documented.
Human CD14+ CD16 monocytes resemble Gr1+ cells based
on surface marker expression and gene expression arrays
(Geissmann et al., 2003; Ingersoll et al., 2010; Strauss-Ayali
et al., 2007) and are reportedly producers of IL-10 and weak
producers of TNF-a in vitro. Human CD16+ monocytes, which
resemble Gr1 cells, are described as the main producers of
inflammatory cytokines such as TNF-a and IL-1b in response to
bacterial lipopolysaccharides (LPSs) (Belge et al., 2002). Recent
work demonstrates distinct responses of human monocyte
subsets to Aspergillus fumigatus conidia (Serbina et al., 2009).munity 33, 375–386, September 24, 2010 ª2010 Elsevier Inc. 375
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Human CD14 Dim MonocytesAlthough both monocyte subsets efficiently phagocytose coni-
dia, CD14+ CD16 monocytes inhibit conidial germination yet
secrete little TNF-a, whereas CD14+ CD16+ monocytes do not
inhibit conidial germination but secrete large amounts of TNF-a
(Serbina et al., 2009). Of note, an additional degree of complexity
was introduced by thework of Grage-Griebenow (Skrzeczynska-
Moncznik et al., 2008) and Scha¨kel (Scha¨kel et al., 2002), indi-
cating that human CD16+ monocytes are not a homogeneous
cell population. Thus, on the one hand it is increasingly clear
that monocyte subsets exert critical specific functions in the
response to microbes, whereas on the other hand the reported
differences in the behavior of monocyte subsets in mice and
human have hampered the description of potential evolutionary
conserved functions (Auffray et al., 2009; Skrzeczynska-Mon-
cznik et al., 2008; Ziegler-Heitbrock, 2007).
The murine population of Gr1 monocytes patrol the blood
vasculature and is therefore ideally located to survey local tissue
damage and infection (Auffray et al., 2007). The present study
was therefore designed to search for putative human functional
homologs to murine Gr1 patrolling monocytes and to charac-
terize the full spectrum of their functions.RESULTS
Human Homologs to Murine Monocytes
Human monocytes can be distinguished from other cell types in
the peripheral blood by flow cytometry (Figure 1 and Figure S1
available online). Large CD14+ CD16monocytes (85% of blood
monocytes) can be distinguished from a population of large
CD14+CD16+ monocytes (5%), on the basis of the level of
expression of CD16, CD62L, CD11c, CD163, and CX3CR1
(Figures 1A–1D and Figure S1). Monocytes expressing low
amounts of CD14 (CD14dim, 7% of monocytes) have a smaller
size and granularity, express CD16, and have lower expression
of CD11b and CD163 (Figures 1A–1D). These small
CD14dimCD16+monocytes can be further subdivided into
CD14dimCD16+ 6-sulfo LacNAc (Slan)+ andCD14dimCD16+Slan
(Figure 1C). Bloodmonocytes Gr1+ andGr1, fromC57/Bl6mice
(n = 3, samples Gr1+1, 2, and 3 and Gr1 1, 2, and 3), were there-
fore compared to the prospective humanmonocyte subsets from
three healthy donors with whole-genome expression arrays (as
described in the Experimental Procedures). For the three healthy
donors, five samples were analyzed for each subset, including
biological replicates from donor 1 (D1 samples 17–19, 19–21,Figure 1. Phenotype, Expression Arrays, and In Vivo Behavior of Huma
(A–D) (A) Monocytes are contained within CD115+ cells, or DR+ cells, that do not e
(CD15). Within this gate, large CD14+CD16 and CD14+CD16+ monocytes, sm
rated. (A and B) The size, morphology, and (C and D) phenotype of monocytes s
(E) Principal component analysis (PCA), using probes with significant statistical v
(F) Hierarchical clustering with the Spearman correlation similarity measure and a
logenes and filtering by fold two.
(G) Hypothesis generated from biostatistical analysis. In (A) and (D)–(G), monocyte
and CD14dim CD16 are dark blue. Within CD14dim CD16 cells, Slan+ cells are
(H) Intravital microscopy of the ear dermis from Cx3cr gfp/+ Rag2/ Il2rg/mice
dextran (red), and murine monocytes express gfp (green). CD14dim human mono
images are stills from Movie S1. The scale bar in (H) represents 50 mm.
(I) Dot plots represent the length and duration of crawling CD14+ monocytes (circ
LFA-1 (triangles) from nine independent experiments.
See also Figure S1 and Movies S1 and S2.
Im23–25, 26–28, and 29–31), and simplicates from donor 2 (32,
33, 34, 35, and 36) and donor 3 (37, 38, 39, 40, and 41) (see
also Supplemental Experimental Procedures). Common ex-
pressed genes between human and mouse chips were selected
with Ingenuity. Principal component analysis (PCA) on the human
data set indicated that CD14+CD16, CD14+CD16+, and
CD14dimCD16+ subsets segregated in independent clusters
(Figure 1E). Expression of Slan did not allow discrimination of
subsets among CD14dimCD16+cells (Figure 1E). Human and
mouse data sets were then merged and submitted to a hierar-
chical clustering with the Spearman correlation similarity
measure with average linkage that used ‘‘all expressed genes’’
and ‘‘fold 2 expressed’’ genes (Figure 1F and Figure S1), and
submitted independently to a PCA with a covariance matrix
(Figure S1). These two unsupervised analyses showed compa-
rable results, summarized in Figure 1G and Figure S1. Results
from the hierarchical clustering analysis using D1, D2, and D3
with all individual D1 biological replicates (Figure 1F), with the
mean of D1 replicates (Figure S1), or with individual replicates
(not shown) were similar and led to an identical conclusion. In
all cases the samples were split into two main groups, each of
which included human and mouse samples. Gr1 murine
samples always segregated with the samples of CD14dim
CD16+ humanmonocytes samples, whereas Gr1+murinemono-
cyte samples segregated with all of the CD14+ human samples,
independently of expression of CD16 (Figure 1F and Figure S1).
These results predicted that the absence of expression of the
CD14 and CD163 antigens distinguishes the putative human
homologs of murine Gr1 ‘‘patrolling’’ monocytes, whereas
both CD14+CD16 and CD14+CD16+ cells would resemble
mouse Gr1+ ‘‘inflammatory’’ monocytes, in contrast to previous
hypotheses (Geissmann et al., 2003; Ingersoll et al., 2010;
Ziegler-Heitbrock, 2007).‘‘Patrolling’’ CD14dim Monocytes
To test this prediction, we purified human monocyte subsets
from peripheral blood by flow cytometry (as described in
Figure S1), labeled them with fluorescent probes, transferred
them intravenously into Rag2/ Il2rg/ Cx3cr1gfp mice, and
examined them by intravital microscopy (Figure 1H and Movies
S1 and S2). Most human CD14dim monocytes attached immedi-
ately to the endothelium after intravenous transfer and crawled
for an extended period of time, whereas crawling was not
observed after intravenous transfer of CD14+ monocytesn Monocyte Subsets
xpress B cell (CD19), T cell (CD2), NK cell (NKp46), or granulocyte markers
all CD14dimCD16+ monocytes, and CD14CD16 dendritic cells can be sepa-
ubsets are shown. The scale bar in (B) represents 20 mm.
ariation between at least two groups.
verage linkage in clustering algorithm with probes corresponding to the homo-
s populations are color coded. CD14+CD16 are yellow, CD14+CD16+ are red,
light blue and Slan cells are magenta.
. Blood vessels are labeled by intravenous (i.v.) injection of fluorescent 70 kDa
cytes are purified by flow cytometry labeled with DiD (cyan) and injected i.v.;
les) and CD14dimCD16+ monocytes before (squares) and after blocking human
munity 33, 375–386, September 24, 2010 ª2010 Elsevier Inc. 377
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Figure 2. Functional Analysis of Monocyte
Subsets
Human monocytes were obtained from whole
blood from healthy donors and purified by flow cy-
tometry as indicated in the Experimental Proce-
dures (see Figure S1).
(A) Percentage of cells that have phagocytosed
1 mm beads after the indicated time. The mean ±
SD of triplicates is shown. A representative of
five independent experiments is shown.
(B) ROS production.
(C) Cytokine production after overnight incubation
with (+) or without () LPS (100 ng/ml).
(D) Production of IL1-RA after 18 hr incubation. Bar
graphs in (B)–(D) show mean ± SD of triplicates,
from experiments representative of three to five
donors. See also Figure S2.
Immunity
Human CD14 Dim Monocytes(Figure 1I), further suggesting that CD14dim monocytes are the
functional homologs of murine ‘‘patrolling’’ Gr1 monocytes.
The ability of human monocytes to attach and crawl on murine
endotheliumwas consistent with interspecies conservation of in-
tegrins, in particular lymphocyte function-associated antigen-1
(LFA-1) (Vidovic et al., 2003),which is critical formurinemonocyte
crawling (Auffray et al., 2007). To test this hypothesis, we there-378 Immunity 33, 375–386, September 24, 2010 ª2010 Elsevier Inc.fore performed intravenous injection of
human LFA1 blocking antibody (clone 38
[Dransfield et al., 1992]), and observed
that it abolished crawling by human
monocytes inside mouse blood vessels
(Figure 1I). These data indicated that
human CD14dim monocytes can patrol
blood vessels in vivo, in a LFA1-depen-
dent manner.
‘‘Inflammatory’’ CD14+CD16– and
CD14+CD16+ Monocytes Respond
to Bacteria-Associated Signals
As expected, CD14+ monocytes were
very efficient at phagocytosing latex
beads (Figure 2A). CD14+CD16 mono-
cytes produced high level of ROS
(Figure 2B) and also expressed more
mRNA formyeloperoxidase and lysozyme
(Figure S2). In the presence of LPS,
CD14+CD16 monocytes produced very
high amounts of a distinct and limited set
of chemokines and cytokines, including
IL-6, IL-8, CCL2, and CCL3 (Figure 2C).
The double-positive CD14+CD16+
monocyte population did not produce
ROS (Figure 2B), expressed mRNA for
myeloperoxidase and lysozyme at low
levels (Figure S2), and produced cyto-
kines distinct from those produced by
CD14+CD16 monocytes (Figure 2C).
They were the main producers of IL-1b
and TNF-a in response to LPS and addi-
tionally produced IL-6 and CCL3 (Fig-ure 2C). CD14+CD16+ also accounted for the bulk of cytokine
production in response to the Toll-like receptor (TLR) 2 agonist
Pam3ck4 (data not shown and Figure S2). Both CD14+CD16
and CD14+CD16+ monocytes produced moderate amount of
the anti-inflammatory cytokine IL-10, with slightly different
kinetics (Figure S2) that may explain previous contradictory
reports (Belge et al., 2002; Skrzeczynska-Moncznik et al., 2008).
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Figure 3. Development of Monocytes in gc-
Deficient Patient and Antigen Presentation
(A) Phenotype of DR+ cells is analyzed by flow
cytometry analysis of blood from gc-deficient
patient (lacking T, B, and NK cells) versus controls.
The bar graph represents the percentage
(mean ± SD) of CD14dim monocytes among DR+
cells in three patients and ten controls.
(B) Antigen presentation assay. Monocyte subsets
and DCs, from a tetanus toxoid-immunized donor
were incubated with autologous T cells and
tetanus toxoid. Thymidine incorporationmeasured
during the last 18 hr. IL-2 is measured after 4 days.
Data in (B) represent the mean ± SD of triplicates,
from experiments representative of three donors.
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Human CD14 Dim MonocytesTherefore, CD14+ monocytes as a population exhibited the
basic characteristics of Gr1+ ‘‘inflammatory’’ TNF-a and ROS-
producing murine monocytes (Serbina et al., 2008). Distinct
cell types within this population, i.e., CD14+CD16 and
CD14+CD16+, are responsible for the bulk production of ROS,
IL-6, IL-8, and CCL2 and of TNF-a and IL-1, respectively, in
the presence of LPS. These observations are in line with the pub-
lished evidence that LPS induces expression of different cyto-
kines by CD14+ and CD16+ monocytes (Belge et al., 2002;
Skrzeczynska-Moncznik et al., 2008). The secretion of type I
IFN, IL-2, IL-4, IL-5, IL-7, IL-9, IL-12, IL-13, IL-15, IL-17,
CCL11, granulocyte colony-stimulating factor (G-CSF), granulo-
cyte-macrophage colony-stimulating factor (GM-CSF), platelet-
derived growth factor (PDGF), and vascular endothelial growth
factor (VEGF) was not detected in monocytes in these experi-
ments (data not shown).‘‘Patrolling’’ CD14dim Monocytes Respond Poorly
to Bacterial Cues
CD14dim cells exhibited a limited ability to uptake latex beads in
comparison to CD14+ monocytes (Figure 2A), did not produce
ROS (Figure 2B), expressed little mRNA for myeloperoxidase
(MPO) and lysozyme (Figure S2), and gave little response to
LPS or to PAM3CK4 TLR1 and two agonists (Figure 2C and
Figure S2). Thus, the production of IL-1b and TNF-a in response
to LPS, previously attributed to the CD16+ fraction ofmonocytes,
is restricted to the double-positive CD14+ CD16+ cells in our
experiments.
As expected from PCA and clustering analysis, CD14dim
monocytes expressed a distinct set of genes in comparison toImmunity 33, 375–386, Seboth CD14+CD16+ and CD14+CD16
monocytes, including chemokine recep-
tors, as well as different sets of apolipo-
proteins, scavenger receptors for lipids
and dying cells, and cytokine receptors
(Figure S2). CD14dim monocytes did not
express inflammatory chemokine recep-
tors such as CCR2 and expressed lower
levels of CCR1, CCR5, IL-17RA, apolipo-
protein (Apo) B48, CD36, MPO, and lyso-
zyme. In contrast, they expressed higher
amounts of IL-10 receptor and CXCL16scavenger receptor ApoA and ApoE (Figure S2) and produced
high amounts of IL-1 receptor antagonist during overnight
culture (Figure 2D). Overall, the monocyte proinflammatory
response, including phagocytosis and the production of ROS,
MPO, lysozyme, and cytokines in response towell-characterized
TLR1, TLR2, and TLR4 signals, appeared to be mediated by
CD14+ monocytes, whereas the profile of CD14dim monocytes
was, if anything, anti-inflammatory in this context.
Are CD14dim Cells Monocytes?
We thus considered the possibility that CD14dim cells might not
be monocytes. Cytologic examination indicated that CD14dim
cells had a morphology compatible with monocytes, and flow
cytometric profiles indicated that they expressed the macro-
phage colony-stimulating factor (MCSF) receptor and CD68,
but low CD11b and CD163 (see Figures 1B–1D). A subset of
human natural killer (NK) lymphocytes express CD16 and HLA-
DR, and recent studies have revealed that NK cells can be
confused for myeloid cells (Blasius et al., 2007; Caminschi
et al., 2007; Vosshenrich et al., 2007). Therefore, we tested the
hypothesis that CD14dim cells might actually represent major
histocompatibility complex (MHC) class II-positive NK cells by
examining cells from patients deficient in the common cytokine
receptor gamma chain (gc); these patients lack all lymphoid line-
ages. We found normal numbers of CD14dim CD16+ cells in three
gc-deficient patients, whereas as expected CD16+NK cells were
absent from these patients (Figure 3A), indicating that CD14dim
cells are not lymphoid.
Cells expressing HLA-DR, CD16, and Slan and negative for
CD14 have also been described as antigen-presenting dendriticptember 24, 2010 ª2010 Elsevier Inc. 379
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Human CD14 Dim Monocytescells (DCs) (Scha¨kel et al., 2006). Both CD14+ and CD14dim
monocytes stimulate allogenous mixed lymphocyte reaction at
high effector/target ratio (Figures S2D and S2E). However, they
do not process and present antigen (Figure 3B). For investigating
the ability of CD14dim CD16+ cells to present a recall protein
antigen to T cells in comparison to other monocyte subsets
and blood DCs, tetanus toxoid was added to coculture of mono-
cytes or DCs and T cells from autologous vaccinated donors
(Sallusto and Lanzavecchia, 1994). Freshly isolated monocytes
from any subset did not promote any significant antigen-
dependent T cell proliferation or IL-2 production ,whereas
CD14CD16 HLA-DR+ DCs are able to efficiently present
tetanus toxoid to T cells and to trigger strong IL-2 production
(Figure 3B). Therefore, CD14dim cells appeared to be unable
to process antigen, and genetic and functional evidence indi-
cated that they are a bona fide monocyte subset. Of note, in
our PCA, CD14dimCD16+Slan+ cells clustered together with
CD14dimCD16+Slan cells and total CD14dimCD16+ cells (see
Figure 1).
CD14dim Monocytes Produce a Selected Set
of Proinflammatory Cytokines in Response to Viruses
The poor response via TLR1 and TLR 2 and via TLR4 does not
preclude the involvement of monocytes in the inflammatory
responses to other classes of pathogens. P. Ancuta and others
have proposed a role for CD16+ monocytes in the immune
response to HIV (Ancuta et al., 2006) and monocytic cells have
been shown to produce inflammatory cytokines in the presence
of viruses (Gupta et al., 2001; Stro¨her et al., 2001). A separate
subset of white blood cells, plasmacytoid DCs, are known to
be the main blood producers of type 1 IFN in response to viruses
(Liu, 2005), although murine Gr1+ monocytes can contribute to
production of type 1 IFN in response to viruses (Barbalat et al.,
2009). Among TLRs that recognize nucleic acids and are
involved in the immune response to viruses (TLR3, TLR7,
TLR8, and TLR9), monocytes weakly express TLR3 and TLR9
and do not respond to TLR3 and TLR9 agonists (Jarrossay
et al., 2001; Kadowaki et al., 2001) (Figure S3). However, human
monocytes express TLR7 and TLR8 (Supplemental figure S3),
the two other endosomal TLRs involved in the immune response
to viruses (Diebold et al., 2004; Heil et al., 2004; Lund et al.,
2004). We thus reasoned that human monocytes subsets may
be involved in the pro-inflammatory response to viruses.
CD14+ monocytes produced very high amounts of the granu-
locyte, B cell, and T cell ‘‘helper’’ chemokines and cytokines IL-6,
IL-8, and CCL2, in response to measles (ssRNA []) and herpes
simplex virus 1 (HSV-1) (dsDNA) at a multiplicity of infection
(MOI) of 1, similar to what was observed for LPS. In contrast,
freshly purified CD16+ monocytes, especially CD14dim CD16+
monocytes, whether Slan+ or Slan, selectively produced very
high amounts of the proinflammatory cytokines TNF-a, IL-1b,
and of CCL3 in response to measles and HSV-1 (Figures 4A
and 4B). Of note, secretion of type I IFN by human monocytes
was very low (not shown).
CD14dim Monocytes Respond to Viruses via a Unique
TLR7-TLR 8-MYD88-MEK-Dependent Pathway
To investigate the mechanisms of cytokine production by
CD14dim and CD14+ monocytes, we examined their response380 Immunity 33, 375–386, September 24, 2010 ª2010 Elsevier Inc.to TLR7 and TLR8 agonists. The response of monocyte subsets
to stimulation with TLR8 agonists (3M2 and R848) and to a lesser
extent to a TLR7 agonist (3M13) was similar to their response to
intact viruses. CD14dim monocytes produced very high amounts
of proinflammatory cytokines, but little IL-6, IL-8, and CCL2,
whereas CD14+ CD16monocytes produced little proinflamma-
tory cytokines, but high IL-6 and IL-8 (Figure 4C). As was true for
responses to viruses, the population of CD14+ CD16+ mono-
cytes displayed an intermediate phenotype (Figure S3).
To investigate whether cytokine production by monocytes
required infectious virus, we incubated monocytes with either
live, ultraviolet light (UV)-inactivated, or heat-inactivated HSV1-
green fluorescent protein (GFP) expressing virus. Control fibro-
blasts exhibited GFP fluorescence only when infected with live
virus (Figure S3). In contrast, monocytes exhibited similar GFP
fluorescence whether they were exposed to live, UV-inactivated,
or heat-treated viruses (Figure S3), probably reflecting uptake
rather than infection. Monocytes produced cytokines in
response to live virus and UV-inactivated virus, but not in
response to denatured virus particles obtained by heat-inactiva-
tion (Figure S3). These data indicate that monocytes are acti-
vated by HSV-1 particles, in line with a TLR-mediated response,
but active HSV-1 replication may not be required for cytokine
production at a MOI of 1. Similarly, replication of measles virus
was not observed at a MOI of 1 (Figure S3).
To confirm the role of TLRs and specifically of TLR7 and TLR8
for cytokine production, we purified CD14dim and CD14+ CD16
monocytes from the peripheral blood of patients deficient in
myeloid differentiation primary response gene 88 (MYD88) and
in some cases in interleukin-1 receptor-associated kinase 4
(IRAK-4) (Picard et al., 2003; von Bernuth et al., 2008) and from
controls and were stimulated with measles virus and/or HSV1.
Production of TNF-a and IL-1b by CD14dim monocytes was
totally dependent onMyD88, whereas production of chemokines
CCL5 and CXCL10 was maintained, likely due to intracytoplas-
mic sensors and interferon-inducible RNA helicase MDA5 and
RIG-I, (Figure 4D). Production of IL-6 and IL-8 by CD14+ CD16-
monocytes also required MYD88 (Figure 4E). Similar results
were obtained with IRAK4-deficient monocytes (Figure 4E). Alto-
gether, these data indicated that cytokine production by mono-
cytes in response to viruses (measles and HSV-1) is mediated via
a TLR-MYD88 pathway, most likely via TLR8 and TLR7. Notably,
TLR3 signaling is largelyMYD88 independent and thus data from
Figures 4D and 4E confirm that TLR3 is not involved in monocyte
activation by viruses.
We then investigated whether selective monocyte subset acti-
vation via TLRs was also a feature of mouse monocytes. Murine
blood monocytes were incubated with LPS or the TLR7 agonist
3M13. Gr1+ monocytes responded both to LPS and TLR7
agonist, whereas Gr1 monocytes responded better to TLR7
agonist than to LPS (Figures S1E and S1F), suggesting a similar
response to TLR agonist by murine Gr1 and human CD14dim
monocytes.
We reasoned that monocyte subsets might display distinct
effector responses (i.e., the production of inflammatory cyto-
kines versus ‘‘helper’’ cytokines) in response to viruses and
TLR7 and TLR8 agonists because different downstream
signaling pathways might be engaged in different cell types. To
test this possibility, we examined activation of various signaling
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Figure 4. Monocyte Subset-Specific Response to Viruses
(A and B) Cytokine production from two different donors after overnight incubation with viruses (A and B) (herpes simplex virus-1 (dsDNA, HSV-1), vesicular
stomatitis virus [ss()RNA, VSV], measles virus [ss()RNA, MV], and Encephalomyocarditis virus [ss(+)RNA, EMCV’.
(C) Cytokine production after overnight incubation with TLR agonists.
(D and E) Cytokine production by CD14dim monocytes (D) and CD14+ monocytes (E) from controls, MYD88-deficient patients and IRAK-4-deficient patients after
exposure to measles virus (MV) or herpes simplex virus-1 (HSV-1). Data are representative of at least three donors. Bar graphs in (A)–(C) show mean (±SD) of
triplicates from experiments representative of five healthy donors. Bar graphs in (D) and (E) show results representative of two IRAK/ patients, three
MYD88/ patients, and ten healthy donors.
See also Figure S3.
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Human CD14 Dim Monocytespathways in different subsets after TLR7 and/or TLR8 activation.
As has been previously observed (Levy et al., 2006), p38
mitogen-activated protein kinase (MAPK) was rapidly phosphor-
ylated in CD14+ monocytes in response to TLR8 agonists. In
contrast, p42 mitogen-activated protein kinase kinase 1
(MEK1) phosphorylation, but not p38 MAPK, was observed
30 min after stimulation in CD14dim monocytes in response to
TLR7 and TLR8 agonists (Figure 5A), followed 90 min later by
Jun N-terminal kinases (JNK) phosphorylation (Figure 5A).
This suggested that different signaling pathways are activated
in monocyte subsets. We therefore investigated whether phar-
macological inhibitors ofMEK1 or p38 affect cytokine production
by monocyte subsets in response to TLR7 and TLR8 agonists.
Production of proinflammatory cytokines in response to TLR7Imand/or TLR8 agonists by CD14dim monocytes was strongly in-
hibited by the MEK1 inhibitor in a dose-dependent manner
(Figure 5B), but not by a p38 inhibitor (Figure S4). In contrast,
production of cytokines by CD14+ monocytes was partially in-
hibited by a p38 inhibitor (30% inhibition, Figure S4) but not by
the MEK1 inhibitor (Figure 5B). Although pharmacological inhib-
itors can have off-target effects, subset-specific responses to
these inhibitors indicate differential involvement of MAPK path-
ways.
Altogether, these data indicate that distinct subset-specific
pathways control cytokine production by monocytes in
responses to viruses and nucleic acids. We propose a model
in which production of IL-6 and IL-8 by CD14+ monocytes
involves activation of p38 in addition to a classical NF-kBmunity 33, 375–386, September 24, 2010 ª2010 Elsevier Inc. 381
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Figure 5. Monocyte Subset-Specific Activation Pathways
(A) Phosphorylated Akt, p38-MAPK, MEK1, and JNK in CD14+(black bars) and CD14lo monocytes (red bars) following treatment with TLR8 agonist (3M2, open
bars) or TLR7 agonist (3M13, closed bars) for 0, 30, and 120 min at 37C. Data are presented as mean fold increase from vehicle control treated cells from three
independent experiments.
(B) Cytokine production by CD14+ (open black bars) and CD14dim (closed red bars) monocytes treated with vehicle, 3M2, or 3M13 with or without MEK inhibitor
PD98059. Data are presented as mean ± SD in expression (pg/ml) from three independent experiments.
See also Figure S4.
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Human CD14 Dim Monocytespathway, whereas production of TNF-a, IL-1, and CCL3 by
CD14dim monocytes is controlled by an alternative p42 MEK
MAP kinase pathway (Figures S4B–S4F).
CD14dim Monocyte-Specific Inflammatory Response
to Self-Nucleic Acids in Patients with Lupus
Intracellular TLRs activated by nucleic acids, and particularly
RNA, have evolved under strong selection, suggesting an essen-
tial role in host survival (Barreiro et al., 2009). However, as
a possible tradeoff mechanism, TLR7- and TLR9-dependent
recognition of endogenous nucleic acids is also a feature of auto-
immune diseases such as systemic lupus erythematosus (SLE),
a disease associated with autoantibodies to nucleosome and
ribonucleoproteins, and immune complex deposition in several
organs (Rahman and Isenberg, 2008). Ribonucleoprotein-con-
taining immune complexes stimulate immune cell such as plas-
macytoid DCs and B cells via TLRs (Lau et al., 2005; Lo¨vgren
et al., 2006).
Although the mechanisms of Lupus-induced tissue damage,
and in particular glomerulonephritis, are poorly understood,
recent work in the mouse has proposed that activation of
myeloid cells by glomerular immune complex, which requires
both FcRg and TLRs (Bergtold et al., 2006; Clynes et al., 1998),
initiates an inflammatory response that results in glomerulone-
phritis. Murine Gr1 monocytes have recently been shown to
be selectively expanded in nephritis, to accumulate inside the
capillary vessels in the nephritic kidney, and to be activated by
immune complexes in an FcRg-dependent manner (Bergtold
et al., 2006). In human, genetic studies studies have associated
CD16 with lupus (Rhodes and Vyse, 2008). It was further shown
that CD16+ monocytes adhere in vitro to endothelial cells better382 Immunity 33, 375–386, September 24, 2010 ª2010 Elsevier Inc.than CD14+monocytes, a phenomenon in part dependent on the
chemokine receptor CX3CR1 (Ancuta et al., 2003), and human
CD14dimCD16+ monocytes patrol capillaries in vivo as shown
in this report (see Figures 1H and 1I). Finally, elevated amounts
of fractalkine (the CX3CR1 ligand) expression and accumulation
of CD16+ monocytes inside glomerular blood vessels has been
documented in human SLE (Hill et al., 2005; Yoshimoto et al.,
2007). In accordance with the literature (Hill et al., 2005; Yoshi-
moto et al., 2007), we confirmed and observed a glomerular
IgG deposition and monocytic infiltrate (CD68+ CD16+ CD14dim
and CD15 CD33) in glomerular vessels from patients with
class IV-G lupus nephritis (Figure 6A).
We thus hypothesized that nucleic acid-containing immune
complexes present in glomerular capillaries activate CD14dim
monocytes to produce TNF-a, IL-1, and CCL3 cytokines that
maydamage theendothelium.Wecompared theeffects of serum
from individuals with SLE and anti-ribonucleoprotein (RNP) anti-
bodies (see Experimental Procedures) on monocyte activation.
Patient sera induced strong production of TNF-a and CCL3 by
CD14dim monocytes isolated from healthy donors, as well as
the production of IL-6 and IL-8 by CD14+monocytes, in compar-
ison with sera from controls (Figure 6B). Sera were then pre-
treated with RNase and DNase, and/or Ig depletion, and/or
addition of ribonucleoprotein, before incubation with monocytes
(Figures 6C and 6D). Both nucleic acids and Ig were observed to
contribute 30%–50% of the production of CCL3 and TNF-a by
CD14dim monocytes; the depletion of nucleic acids and Ig
together did not have an additive effect on inhibition. These
results indicated that in addition to TLR7-TLR8 agonists, and
viruses, ribonucleoprotein-containing immune complexes
induce CCL3 and TNF-a production by CD14dim monocytes.
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Figure 6. CD14dim Monocytes Detect Nu-
cleic Acids and Mediate Inflammation in
Lupus Patients
(A) Immunostaining for IgG, CD68, CD16, CD14,
CD15, and CD33, on tissue sections from kidney
biopsy with IV-G lupus glomerulonephritis (left
panels) and postinfectious glomerulonephritis
(right panels).
(B) Cytokine production by CD14dim or CD14+
monocytes from healthy controls (n = 3) incubated
with serum from Lupus patients with autoanti-
bodies to RNPs (n = 3) and controls (n = 2).
(C and D) Monocyte cytokine production after
incubation with serum from patients without treat-
ment (open bar), RNase+DNase treatment (red
bar), addition of RNP (light yellow bar), depletion
of immunoglobulins (green bar), depletion of
immunoglobulins+RNP (blue bar), or depletion of
immunoglobulins+RNase+DNase (orange bar).
Two representative figures for each cytokine
from at least three experiments are shown.
*p < 0.01 for comparison RNP versus other treat-
ments (one-way ANOVA).
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This study establishes CD14dim humanmonocytes as a bona fide
myeloid immune cell population that patrol blood vessels and
exert specific effector functions in the inflammatory response
to viruses and nucleic acids. Genome-wide expression analysis
(Figure 1) predicted that these monocytes, which lack CD14
expression (CD14dim) and represent a minority (7%) of human
blood monocytes, resemble mouse ‘‘patrolling’’ Gr1 mono-
cytes and can be distinguished from lymphoid cells, dendritic
cells, andCD14+CD16 andCD14+CD16+monocytes. CD14dim
monocytes patrol capillaries after adoptive transfer in vivo, do
not produce ROS, exhibit low or absent myeloperoxidase and
lysozyme production in a steady state, constitutively produce
IL-1RA, and are weak producers of inflammatory cytokines after
exposure to LPS or a TLR1 and TLR2 agonist. NeverthelessImmunity 33, 375–386, SeCD14dim cells belong to the monocytic
lineage, given that they develop in indi-
viduals lacking lymphoid precursors due
to loss of function mutations in X-linked
common g chain, implying that they are
developmentally distinct from NK CD16+
lymphocytes. CD14dim monocytes ex-
hibited an anti-inflammatory phenotype
in a steady state and respond poorly to
surface-associated TLR stimulation, but
specialize in the production of the proin-
flammatory cytokines TNF-a, IL-1b, and
of CCL3 in response to viruses and nu-
cleic acids, via a unique TLR7-8, MyD88
and MEK-dependent pathway. Of note,
murine ‘‘patrolling’’ Gr1 monocytes
also responded better to TLR7 agonist
than to LPS (Figure S1), suggesting
a degree of functional similarity between
human and murine patrolling monocytes.Although they can stimulate the proliferation of allogenic
T cells at high effector-to-target ratio (Sallusto and Lanzavec-
chia, 1994), blood monocytes, including the CD14dim subset,
do not process and present a recall antigen to T cells, in contrast
to blood DCs. This is in contrast to some previous reports that
identified DCs as a population expressing CD16 and Slan (Scha¨-
kel et al., 2002). However, we observed that monocytes, in
particular the CD14dim subset, can promote autologous T cell
proliferation, in an antigen-independent manner, and without
detectable increase in IL-2 production. Therefore, although
monocytes are clearly distinct from DCs, further studies will be
needed to clarify the functional outcomes of their interaction
with T cells (Evans et al., 2009).
Reported differences in the behavior of monocyte subsets in
mice and human (Auffray et al., 2009; Skrzeczynska-Moncznik
et al., 2008; Ziegler-Heitbrock, 2007) have stimulated efforts toptember 24, 2010 ª2010 Elsevier Inc. 383
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Human CD14 Dim Monocytesidentify human homologs to monocyte subsets (Ingersoll et al.,
2010). The PCA and hierachical clustering analysis reported
here suggested that monocytes expressing CD14 (CD14+),
which represent more than 90% of blood monocytes, resemble
mouse ‘‘inflammatory’’ Gr1+ monocytes, whether or not they
express CD16. Indeed, they share their key functional character-
istics; they are responsible for phagocytosis, ROS production,
and cytokine production in response to LPS via a classical
MyD88-, p38-, and NF-kB dependent pathway. Within this
subset, distinct cells, i.e., CD14+CD16 and CD14+CD16+ cells,
are responsible for the bulk of ROS, IL-8, and IL-6 production
and for TNF-a and IL-1 production respectively in response to
LPS. This observation may appear different from a recent work
that concluded that CD14+ CD16monocytes were homologous
to mouse Gr1+ monocytes, whereas CD14+ CD16+ monocytes
were homologous to mouse Gr1 monocytes (Ingersoll et al.,
2010). However, this discrepancy can be accounted for by the
fact that the Ingersoll study compared only two human subsets
(CD14+ CD16 monocytes and human CD16+ monocytes) with
two murine subsets (Gr1+ and Gr1 monocytes). Their CD16+
monocyte population may have contained both the CD14dim
subset and the CD14+ CD16 subset.
We therefore propose that CD14dim CD16+ monocytes repre-
sent a monocyte subset that patrol blood vessels and selectively
detect virally infected and damaged cells to produce proinflam-
matory cytokines. This role of CD14dim CD16+ monocytes is
reminiscent of the main function of plasmacytoid DCs (PDCs),
which are also specialized in response to viral stimulation via
TLR7 and TLR9 (Liu, 2005). However, PDCs secrete type I inter-
ferons, whereas CD14+ monocytes produce IL-6 and IL-8, and
patrolling monocytes produce TNF-a, IL-1b, and CCL3, thus
exhibiting complementary functions in the TLR-dependent anti-
viral response. Of note, we did not detect significant secretion of
type I interferon by either CD14+ or CD14dim monocytes in this
study. In the murine system Gr1+ monocytes (which resemble
CD14+ human monocytes) secrete IFN-b after activation by
viruses (Barbalat et al., 2009).
During antiviral responses, a systemic type 1 interferon
response is triggered by PDCs and Gr1+ monocytes and a local
type 1 interferon response by infected fibroblasts andother tissue
cells. Our data suggest that in addition, monocytes and in partic-
ular patrolling CD14dim monocytes, participate in a regional anti-
viral response characterized by the production of proinflamma-
tory cytokines such as TNF-a and IL-1b and of CCL3 and are
potentially involved in virus-induced immunopathology.
PCA and functional experiments indicated that CD14+CD16,
CD14dim and CD14+CD16+ monocytes represent distinct cell
populations. The expression of CD16 by CD14+ monocytes
may correspond to an activation and/or differentiation state of
CD14+ monocytes, as suggested by several groups (Ziegler-
Heitbrock, 2000). They both respond to extracellular TLR such
as TLR4 and TLR2 and share a high phagocytic index.
In some donors the CD14+CD16+ population displayed an
intermediate cytokine response to viruses and TLR7- TLR8
agonists between that of CD14dim and CD14+CD16 mono-
cytes, and future studies will need to investigate potential
heterogeneity of this ‘‘double positive’’ population. Although it
is conceivable that CD14dim may also derive from CD14+ mono-
cytes, there is no experimental evidence to support this claim,384 Immunity 33, 375–386, September 24, 2010 ª2010 Elsevier Inc.and results from this study argue that, whether CD14dim arise
from CD14+ monocytes or directly from progenitors, their
distinct morphology, behavior in vivo, and signal transduction
apparatus make them two independent functional cell types.
Results presented here indicate that a TLR7-8, MyD88, and
MEK pathway is critical for the secretion of a distinct set of cyto-
kines by CD14dim monocytes, whereas p38 is important in the
MyD88-dependent response of CD14+ monocytes. Activation
of MAPK ERK1 and ERK2 has been previously shown to play
an important role in regulating cytokine production by murine
myeloid cells (Agrawal et al., 2006), and the regulation of distinct
cytokine genes by different members of the MAPK family (ERK
versus p38 MAPK) has been previously reported in DCs (Dillon
et al., 2004). We used computational modeling to examine the
potential relevance of this model. Computational modeling of
this forward biochemical cascades for TLR7 and TLR8 signaling
in monocyte subsets simulates in silico TNF-a, IL-1b, IL-8, and
IL-6 expression profiles that are consistent with our experimental
data. However, more investigations will be needed to define the
consequences of distinct signaling pathways being involved in
the effector functions of monocyte subsets.
TLR7 and TLR8 have evolved under strong selection, indi-
cating an essential role in host survival (Barreiro et al., 2009).
Our present identification of a specific human monocyte subset
relying on TLR7 and TLR8 to detect viruses and nucleic acids for
the production of the proinflammatory cytokines TNF-a and
IL-1b further suggests that TLR7 and TLR8 are endowed with
an essential physiological role. However, there have been no
reports of susceptibility to viral infections in human patients
with impaired MYD88 and IRAK-4 signaling, who are unrespon-
sive to TLR7, TLR8, and TLR9 (Ku et al., 2007; von Bernuth et al.,
2008; Yang et al., 2005). Patients unresponsive to TLR3, TLR7,
TLR8, and TLR9 (UNC-93B deficiency) share the narrow viral
phenotype of TLR3-deficient patients, with herpes simplex
encephalitis (Casrouge et al., 2006; Zhang et al., 2007). Thus,
TLR7 and TLR8 are apparently redundant for host defense
against most common viruses, although it is possible that
TLR7 and TLR8 are required for the defense against yet uniden-
tified virus(es). Alternatively, they may have been selected by
virtue of their role in recognition of endogenous nucleic acids.
In support of a role in the sensing of endogenous nucleic acids
for TLR7-TLR8 expressing monocytes, our results indicate that
activation of CD14dim monocytes by endogenous nucleic acids
can contribute to the pathogenesis of inflammatory autoimmune
diseases such as SLE, during which immune complexes con-
taining nucleoproteins accumulate in tissues and in particular
the glomeruli. Because glomerular damage associated with
SLE leads to kidney failure, requiring dialysis or transplantation,
CD14dim monocytes may therefore represent a potentially useful
cellular therapeutic target in selected inflammatory diseases.
EXPERIMENTAL PROCEDURES
Monocyte Phenotyping and Purification
Anticoagulated whole blood was collected from healthy volunteers, MYD88-
deficient, IRAK-4-deficient, and gc-deficient patients after informed consent.
Red blood cell lysis was used to avoid activation of monocytes by ficoll density
centrifugation. Monocytes (CD14+CD16, CD14dimCD16+ and CD14+CD16+
cells) were analyzed and purified as described in Figure S1 and the Supple-
mental Experimental Procedures.
Immunity
Human CD14 Dim MonocytesIntravital Microscopy and Adoptive Transfer
Intravital microscopy and adoptive transfer were performed as described in
the Supplemental Experimental Procedures.
Array Analysis
Samples
The human samples come from three different healthy donors (D1, D2, and D3)
but the samples from donor D1 are in triplicate. Twenty-five ‘‘Whole Human
Genome’’ chips were therefore obtained from five prospective subsets and
three different donors, including triplicate samples from one donor (see
Supplemental Experimental Procedures). Six ‘‘Whole Mouse Genome’’
chips from Gr1+ and Gr1 mouse monocyte subsets were generated as
described (Auffray et al., 2007). MIAME data are available at www.ebi.
ac.uk/arrayexpress: Geissman_Miltenyi_Human, ArrayExpress accession:
E-MEXP-2544 and Geissman_Miltenyi_Mouse: ArrayExpress accession:
E-MEXP-2545.
We submitted this series of expression arrays to an unsupervised analysis in
order to unveil possible correspondences between samples from the two
species. The two sets of data were obtained and processed independently
as described in the Supplemental Experimental Procedures.
Stimulation of Monocytes
CD14hiCD16lo, CD14loCD16hi, and CD14hiCD16hi cells were sorted from the
blood of healthy controls, and MyD88 and IRAK deficient patients when indi-
cated, as described in the Supplemental Experimental Procedures.
TLR Agonist Stimulations. A total of 104 cells/well were laid in a 96-well plate
in 100 mL and stimulated with PBS control or TLR agonists. Optimal concentra-
tion of TLR agonists were determined in preliminary experiments. In the exper-
iments reported in this paper, the following concentration were used: LPS
(TLR4 agonist) 1 ng/ml, Pam3ck4 (TLR2) 100 mg/mL, 3M2 (TLR8) 3 mg/ml,
R838 (TLR8) 3 mg/ml, and 3M13 (TLR7) 3 mg/ml, in 10% FCS, 1% P/S, and
incubated for 6, 24, or 48 hr at 37C and 5%CO2. When indicated, monocytes
were preincubated (30 min) with the MEK inhibitor PD98059 (10–100 mM), the
P38 inhibitor SB-203580 (50 mM), or DMSO vehicle control before exposure to
TLR agonists.
Viral Stimulations. We stimulated 2 3 104 monocytes or peripheral blood
mononuclear cells (PBMCs) per well from controls and, when indicated,
from MYD88-deficient and IRAK-4-deficient patients, with the indicated intact
viruses (Yang et al., 2005) at a multiplicity of infection of 1 and placed on ice for
30 min to obtain a synchronous infection. Cell supernatant was collected and
analyzed for cytokine production with the Biorad multiplex assay or ELISA
tests.
Human Serum. Human serumwere obtained and treated as described in the
Supplemental Experimental Procedures. ROS production, phagocytosis
assay, antigen presentation assay, cytokine measurements, protein phos-
phorylation, and histological studies were performed as described in the
Supplemental Experimental Procedures.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession numbers
E-MEXP-2544 and E-MEXP-2545.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two movies and can be found with this article online at
doi:10.1016/j.immuni.2010.08.012.
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